Oil is taking a major breather today
Major indexes are in recovery mode today, as tensions and worries eased surrounding potential attack escalations out of Iran and Israel. The Dow Jones Industrial Average (DJI) is up more than 400 points, while the tech-heavy Nasdaq Composite (IXIC) is comfortably higher as well. The S&P 500 Index (SPX) also sits in the black, as West Texas Intermediate (WTI) July-dated oil is taking a breather, last seen down 3.2%.
Continue reading for more on today's market, including:
- Analyst says "buy" this beverage stock.
- Bezos boost sends streaming giant higher.
- Plus, drug stock slides on trial death; healthcare name charging higher; and oil stock being dragged alongside sector.
Sarepta Therapeutics Inc (NASDAQ:SRPT) is popular in the options pits today, with 21,000 calls and 12,000 puts across the tape so far. This represents 14 times the average daily options volume, with the June 20 call and 20 put, where both contracts are being sold to open. Dragging the equity is news a second death has taken place under its muscular dystrophy drug Elevidys. SRPT is down 84% year to date.
Healthcare giant Hims & Hers Health Inc (NYSE:HIMS) is one of the best performers on the New York Stock Exchange (NYSE) today, last seen up 9.2% at $36.18, continuing its volatile performance after last week's announcement its will acquire U.K.-based Zava. The equity tapped a more than two-month peak of $59.29 on June 4, and is up 152% in 2025.
Crude name SM Energy Co (NYSE:SM) is one of the worst stocks on the NYSE today, down 3.7% to trade at $27.19, at last check, falling with oil prices. The shares are looking to snap a six-day win streak and add to an already steep, 30% year-to-date deficit. Overhead, the 100-day moving average has capped its recent breakout attempt.
